USA launches Section 232 investigation into pharmaceuticals

Strengthening free trade, dismantling customs duties

Overview and position on free trade and international market access

Action plan: One Health approach to combating antimicrobial resistance

Overview and position on antibiotic resistance

Promoting research into new antibiotics - but how?

Containing resistances: Antibiotic monitoring in veterinary medicine

Full association with Horizon – why EU research ties matter to CH

Overview and position on relations with the EU

25 years of bilateral agreements: a model of success for Switzerland

Guest article Allnews: Director Stephan Mumenthaler

Full association to Horizon Europe essential

Interview by NZZ: Matthias Leuenberger, President scienceindustries

30 Years EU Single Market: Significance for Switzerland

What happens after the failed negotiations on the (InstA)?